Bleeding symptoms in carriers of hemophilia A and B. 1988

E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
Van Creveld Clinic, Bilthoven, The Netherlands.

In order to investigate the bleeding tendency in clinically identified carriers of hemophilia, a self-administered questionnaire was held among 135 carriers of hemophilia A and B, 25 females with relatives with hemophilia and a matched group consisting of 60 females without relatives with hemophilia. Carriers of hemophilia appeared to suffer more often from bleeding than their relatives or the matched unrelated control group. A relation was seen between factor VIII:C or IX:C activity and the tendency to bleed. Obligatory carriers with normal factor VIII:C levels showed no bleeding tendency and were in this respect similar to a group of 25 females with relatives with hemophilia. This study shows that it is important to assay factor VIII:C or IX:C also in those women in whom the carrier status has already been established otherwise.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001760 Bleeding Time Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. Aspirin Tolerance Test,Bleeding Time, Template,Duke Method,Ivy Method,Template Bleeding Time,Aspirin Tolerance Tests,Bleeding Times,Bleeding Times, Template,Method, Duke,Method, Ivy,Template Bleeding Times,Test, Aspirin Tolerance,Tests, Aspirin Tolerance,Time, Bleeding,Time, Template Bleeding,Times, Bleeding,Times, Template Bleeding,Tolerance Test, Aspirin,Tolerance Tests, Aspirin
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002836 Hemophilia B A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008) Christmas Disease,Factor IX Deficiency,Deficiency, Factor IX,F9 Deficiency,Haemophilia B,Hemophilia B Leyden,Hemophilia B(M),Plasma Thromboplastin Component Deficiency,Bs, Hemophilia,Deficiencies, F9,Deficiencies, Factor IX,Deficiency, F9,Disease, Christmas,F9 Deficiencies,Factor IX Deficiencies,Haemophilia Bs,Hemophilia Bs,Hemophilia Bs (M)
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females

Related Publications

E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
January 2022, BioMed research international,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
May 2014, Journal of pediatric hematology/oncology,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
January 1966, Bibliotheca haematologica,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
May 2009, Journal of thrombosis and haemostasis : JTH,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
November 2008, Journal of thrombosis and haemostasis : JTH,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
April 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
December 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
December 1992, Casopis lekaru ceskych,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
April 2024, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
E P Mauser Bunschoten, and J C van Houwelingen, and E J Sjamsoedin Visser, and P J van Dijken, and A J Kok, and J J Sixma
January 2005, Gaceta medica de Mexico,
Copied contents to your clipboard!